Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00111735Phase 4Unknown
Phase 4, randomised, double-blind trial of levothyroxine sodium in primary hypothyroidism (PH) (3 arms), sponsored by Sir Charles Gairdner Hospital. Primary endpoint: Visual Analog Scales for Wellbeing. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00111735.